{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:52:31Z","timestamp":1762865551258},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/bf03033936","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T13:58:17Z","timestamp":1248098297000},"page":"173-178","source":"Crossref","is-referenced-by-count":23,"title":["The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome"],"prefix":"10.1007","volume":"9","author":[{"given":"Dee Anna","family":"Glaser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,7]]},"reference":[{"key":"BF03033936_CR1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archderm.139.2.226","volume":"139","author":"LS Baumann","year":"2003","unstructured":"Baumann LS (2003) Systemic adverse events after botulinum toxin type B (Myobloc) injections for the treatment of palmar hyperhi-drosis.Arch. Dermatol. 139, 226\u2013227.","journal-title":"Arch. Dermatol."},{"key":"BF03033936_CR2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.0007-1323.2001.01982.x","volume":"89","author":"AJF Beerens","year":"2002","unstructured":"Beerens AJF and GB Snow (2002) Botulinum toxin A in the treatment of patients with Frey syndrome.Br. J. Surg. 89, 116\u2013119.","journal-title":"Br. J. Surg."},{"issue":"9","key":"BF03033936_CR3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/S0022215100138769","volume":"111","author":"A Bjerkhoel","year":"1997","unstructured":"Bjerkhoel A and O Trobbe (1997) Frey\u2019s syndrome: treatment with botulinum toxin.J. Laryngol. Otol. 111(9), 839\u2013844.","journal-title":"J. Laryngol. Otol."},{"issue":"4","key":"BF03033936_CR4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2230.1996.tb00093.x","volume":"21","author":"Ko Bushara","year":"1996","unstructured":"Bushara Ko, DM Park, JC Jones and HS Schutta (1996) Botulinum toxin \u2014 a possible new treatment for axillary hyperhidrosis.Clin. Exp. Dermatol. 21(4), 276\u2013278.","journal-title":"Clin. Exp. Dermatol."},{"key":"BF03033936_CR5","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00415-002-0929-4","volume":"249","author":"D Dressler","year":"2002","unstructured":"Dressler D, F Adib Saberi and R Benecke (2002) Botulinum toxin type B for treatment of axillary hyperhidrosis.J. Neurol. 249, 1729\u20131732.","journal-title":"J. Neurol."},{"key":"BF03033936_CR6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/hed.10262","volume":"25","author":"A Eckardt","year":"2003","unstructured":"Eckardt A and C Kuettner (2003) Treatment of gustatory sweating (Frey\u2019s Syndrome) with botulinum toxin A.Head Neck 25, 624\u2013628.","journal-title":"Head Neck"},{"key":"BF03033936_CR7","unstructured":"Glaser DA, N Solish, MK Naumann, H Hamm, NJ Lowe, A Benohanian and JW Kowalski (2004) Botulinum toxin type A improves occupational impairment associated with primary axillary hyperhidrosis and results in high levels of satisfaction with treatment. Poster-abstract at Summer American Academy Dermatology meeting. New York."},{"key":"BF03033936_CR8","unstructured":"Glaser DA, JW Kowalski, Y Weng, A Ravel, S Daggett, M Nordquist and N Eadie (2005) Effect of repeated botulinum toxin type-A treatment on quality of life and functioning in patients with severe primary axillary hyperhidrosis: results from 2 years longitudinal data. Poster 43, Am. Acad. Dermatol. Annual Summer Meeting Chicago."},{"key":"BF03033936_CR9","unstructured":"Glaser DA, JW Kowalski, N Eadie, N Solish, A Ravelo, Y Weng and PR Reese (2006) Hyperhidrosis disease severity scale (HDSS): validty and reliability results from three studies. (in press)."},{"key":"BF03033936_CR10","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00005537-200204000-00027","volume":"112","author":"O Guntinas-Lichius","year":"2002","unstructured":"Guntinas-Lichius O (2002) Increased botulinum toxin type A dosage is more effective in patients with Frey\u2019s Syndrome.Laryngoscope 112, 746\u2013749.","journal-title":"Laryngoscope"},{"issue":"8-9","key":"BF03033936_CR11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00403-003-0440-5","volume":"295","author":"MJ Hecht","year":"2004","unstructured":"Hecht MJ, F Birklein and M Winterholler (2004) Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study.Arch. Dermatol. Res. 295(8-9), 318\u2013319.","journal-title":"Arch. Dermatol. Res."},{"key":"BF03033936_CR12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2003.12.029","volume":"51","author":"J Hornberger","year":"2004","unstructured":"Hornberger J, K Grimes, M Naumann, DA Glaser, NJ Lowe, H Nayer, S Ahn and LP Stolman (2004) Multi-specialty working group on the recognition, diagnosis, and treatment of primary focal hyperhidrosis.J. Am. Acad. Dermatol. 51, 274\u2013286.","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"BF03033936_CR13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2133.2004.06250.x","volume":"151","author":"GM Kavanuagh","year":"2004","unstructured":"Kavanuagh GM, C Oh and K Shams (2004) Botox delivery by iontophoresis.Br. J. Dermatol. 151(5), 1093\u20131095.","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"BF03033936_CR14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.joms.2003.09.015","volume":"62","author":"DE Kyrmizakis","year":"2004","unstructured":"Kyrmizakis DE, A Pangalos, CE Papadakis, J Logothetis, NJ Maroudias and ES Helidonis (2004) The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes.J. Oral. Maxillofac. Surg. 62(7), 840\u2013844.","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"BF03033936_CR15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/000348949810700110","volume":"107","author":"O Laccourreye","year":"1998","unstructured":"Laccourreye O, L Muscatelo, B Bonan, C Naude and D Bransu (1998) Botulinum toxin type A for Frey\u2019s syndrome: apreliminary prospective study.Ann. Oto. Rhino. Laryngol. 107, 52\u201355.","journal-title":"Ann. Oto. Rhino. Laryngol."},{"key":"BF03033936_CR16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005537-199803000-00013","volume":"108","author":"R Laskawi","year":"1998","unstructured":"Laskawi R, C Drobik and C Schonebeck (1998) Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey\u2019s Syndrome).Saryngoscope 108, 381\u2013384.","journal-title":"Saryngoscope"},{"key":"BF03033936_CR17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","volume":"323","author":"M Naumann","year":"2001","unstructured":"Naumann M and NJ Lowe (2001) Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.BMJ 323, 596\u2013599.","journal-title":"BMJ"},{"key":"BF03033936_CR18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ana.410420619","volume":"42","author":"M Naumann","year":"1997","unstructured":"Naumann M, M Zellner, K Toyka and K Reiners (1997) Treatment of gustatory sweating with botulinum toxin.Ann. Neurol. 42, 973\u2013975.","journal-title":"Ann. Neurol."},{"issue":"6","key":"BF03033936_CR19","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1046\/j.1365-2133.2002.05059.x","volume":"147","author":"MK Naumann","year":"2002","unstructured":"Naumann MK, H Hamm and NJ Lowe (2002) Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.Br. J. Dermatol. 147 (6), 1218\u20131226.","journal-title":"Br. J. Dermatol."},{"key":"BF03033936_CR20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0190-9622(89)70063-3","volume":"20","author":"K Sato","year":"1989","unstructured":"Sato K, WH Kang, K Saga and KT Sato (1989) Biology of sweat glands and their disorders. Normal sweat gland function.J. Am. Acad. Dermatol. 20, 537\u2013561.","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"BF03033936_CR21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaad.2003.12.040","volume":"51","author":"DR Strutton","year":"2004","unstructured":"Strutton DR, JW Kowalski, DA Glaser and PE Stang (2004) US Prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.J. Am. Acad. Dermatol. 51(2), 241\u2013248.","journal-title":"J. Am. Acad. Dermatol."},{"key":"BF03033936_CR22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1468-1331.2001.00207.x","volume":"8","author":"C Swartling","year":"2001","unstructured":"Swartling C, H Naver and M Lindberg (2001) Botulinum A toxin improves life quality in severe primary focal hyperhidrosis.Eur. J. Neurol. 8, 247\u2013252.","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"BF03033936_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archotol.127.3.339","volume":"127","author":"V Tugnoli","year":"2001","unstructured":"Tugnoli V, R Marchese Ragona, R Eleopra, D De Grandis and C Montecucco (2001) Treatment of Frey syndrome with botulinum toxin type F.Arch. Otolaryngol. Head Neck Surg. 127(3), 339\u2013340.","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"12","key":"BF03033936_CR24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-4632.2004.02304.x","volume":"43","author":"J Vadoud-Seyedi","year":"2004","unstructured":"Vadoud-Seyedi J (2004) Treatment of plantar hyperhidrosis with botulinum toxin.Int. J. Dermatol. 43(12), 969\u2013971.","journal-title":"Int. J. Dermatol."}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03033936\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T20:44:53Z","timestamp":1558557893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03033936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":24,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["BF03033936"],"URL":"https:\/\/doi.org\/10.1007\/bf03033936","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}